Loading...

    Explore
    • Policy Monitoring
    • Live Policy Feed
    • Billing Codes
    • Healthcare Providers
    • Health Insurance Payers
    • States
    • Service Lines
    • Taxonomy Codes
    Lookup tools
    • Billing Code Lookup
    • CPT Modifier Lookup
    • Provider Taxonomy Code Lookup
    • Healthcare Provider & Facility Lookup
    • Health Insurance Payer Lookup
    • Payer Contact Directory

    Policy & Benchmark Tools

    • Prior Authorization Lookup
    • Coverage Criteria Lookup
    • Timely Filing Lookup
    • Billing Code Reimbursement Rates
    • Payer Comparison Dashboard
    • Facility Comparison Dashboard
    • All tools

    Company

    • About OpenPayer
    • Data Sources
    • Trek Health
    OpenPayerby Trek Health
    LinkedInYouTube

    © 2026 Trek Health. All rights reserved.

    OpenPayer is built and maintained by Trek Health.

    v1.0.31
    OpenPayerPolicy UpdatesRadiology/Diagnostic ImagingRegence Wireless Capsule Endoscopy Coverage | Open…
    Ask Trek AI about this page
    CurrentRegence BlueCross BlueShieldPolicy 38

    Wireless Capsule Endoscopy for Gastrointestinal (GI) Disorders

    Customize your policy alerts

    Sign up for regence Policy 38 alerts

    Get alerted when Policy 38 changes without checking for updates manually.

    Monitor payer policy activity

    Receive email alerts as soon as relevant payer policies are published or updated.

    This policy governs coverage of wireless capsule endoscopy, primarily for evaluation of the small bowel in members with suspected bleeding, Crohn's disease, hereditary GI polyposis syndromes, or celiac disease. It also identifies capsule endoscopy uses and related capsule technologies considered investigational and specifies documentation needed for medical-necessity review.

    Policy Summary
    PayerRegence BlueCross BlueShield
    PolicyWireless Capsule Endoscopy for Gastrointestinal (GI) Disorders
    Policy CodePolicy N/A
    Change TypeNo material change
    Effective DateAugust 1, 2026
    Last ReviewMar 1, 2026
    Next Review DateJanuary 1, 2027
    Key ActionSubmit clinical documentation supporting the medical-policy criteria for review.
    SourceLink
    POLICY UPDATE CHANGES

    No material clinical or coverage changes in this revision.

    4Medically necessary small-bowel indications
    5Investigational categories
    4Documentation categories
    8 hoursCapsule battery life

    OpenPayer is powered by Trek Health's payer performance platform. Trek continuously ingests, validates, and normalizes Transparency in Coverage data alongside payer policies and other commercial payer data to create a structured payer intelligence foundation. OpenPayer uses this foundation to deliver personalized search results, dynamically generated policy pages, and tailored policy monitoring based on each user's payers, specialties, billing codes, and areas of interest. The same intelligence powers broader payer performance workflows, including reimbursement benchmarking, contract evaluation, payer negotiations, and financial decision-making.

    3
    Primary medically necessary indication groups

    Coverage Criteria

    Medically Necessary Small-Bowel Wireless Capsule Endoscopy

    Wireless capsule endoscopy of the small bowel may be considered medically necessary when at least one covered indication is met.

    ONE or more of the following

    • Evaluation of suspected small bowel bleeding when prior upper and lower gastrointestinal endoscopic studies performed during the current episode of illness are inconclusive and clinical documentation of suspected gastrointestinal bleeding is provided, including anemia (such as iron-deficiency anemia), a positive fecal occult blood test, or visible bleeding.
    • Evaluation of Crohn's disease in an established diagnosis when there are unexpected changes in the course of disease or response to treatment suggesting that the initial diagnosis may be incorrect and reexamination may be indicated.
    • Initial diagnosis of suspected Crohn's disease when clinical documentation shows abdominal pain or diarrhea plus at least one sign of inflammation, such as fever, elevated white blood cell count, elevated erythrocyte sedimentation rate, elevated C-reactive protein, bleeding, terminal ileitis, or another nondiagnostic inflammatory finding, and the diagnosis has not been confirmed by conventional diagnostic tests.
    • Small-bowel surveillance in patients with hereditary gastrointestinal polyposis syndromes, including familial adenomatous polyposis and Peutz-Jeghers syndrome.
    • Evaluation of celiac disease when there is clinical evidence of celiac disease and positive celiac-specific serology but upper endoscopy with biopsy is not indicated, or re-evaluation of celiac disease in an individual who remains symptomatic despite treatment.

    Investigational Uses and Technologies

    Wireless capsule endoscopy is investigational when the medically necessary criteria are not met and for the following indications and technologies.

    Investigational indications and technologies

    • Small-bowel evaluation not meeting the medically necessary criteria.
    • Evaluation of the extent of known Crohn's disease or ulcerative colitis.
    • Evaluation of the esophagus, including gastroesophageal reflux and other esophageal pathologies.
    • Evaluation of gastrointestinal diseases and conditions not presenting with gastrointestinal bleeding, including irritable bowel syndrome, hereditary nonpolyposis syndromes such as Lynch syndrome, small-bowel neoplasm, portal hypertensive enteropathy, and unexplained chronic abdominal pain.
    • Evaluation of the colon, including detection of colonic polyps or colon cancer.

    Suspected Small Bowel Bleeding

    For suspected small-bowel bleeding, wireless capsule endoscopy is intended to confirm the diagnosis and inform a decision to proceed to appropriate treatment.

    ALL of the following

    • The individual has recurrent or obscure gastrointestinal bleeding with suspected small-bowel bleeding.
    • Prior upper and lower gastrointestinal endoscopic studies performed during the current episode of illness are inconclusive.
    • Clinical documentation of suspected gastrointestinal bleeding is provided, including anemia, a positive fecal occult blood test, or visible bleeding.
    • The examination is used to locate the bleeding source and direct treatment to that source.

    Established Crohn's Disease

    For established Crohn's disease, wireless capsule endoscopy is intended to inform management decisions based on disease status.

    ALL of the following

    • Crohn's disease has been previously diagnosed.
    • There is an unexpected change in the course of disease or response to treatment suggesting that the initial diagnosis may be incorrect or that reexamination is indicated.
    • The results will inform management decisions based on current disease status.

    Suspected Crohn's Disease

    For suspected Crohn's disease, wireless capsule endoscopy is intended to confirm a diagnosis and inform a decision to proceed to appropriate treatment.

    ALL of the following

    • Clinical documentation shows abdominal pain or diarrhea plus at least one sign of inflammation, such as fever, elevated white blood cell count, elevated erythrocyte sedimentation rate, elevated C-reactive protein, bleeding, terminal ileitis, or another inflammatory finding that is nondiagnostic on conventional tests.
    • The diagnosis has not been confirmed by conventional diagnostic tests, which may include small-bowel follow-through, upper and lower endoscopy, MR enterography, or CT enterography.
    • The examination is being performed to confirm the diagnosis and inform treatment planning.

    Celiac Disease

    Wireless capsule endoscopy may be considered medically necessary for celiac disease in the following circumstances.

    ONE of the following

    • Clinical evidence of celiac disease and positive celiac-specific serology when upper endoscopy with biopsy is not indicated.
    • Re-evaluation of an individual with celiac disease who remains symptomatic despite treatment.

    Unexplained Chronic Abdominal Pain

    The purpose of wireless capsule endoscopy for unexplained chronic abdominal pain is to confirm a diagnosis and inform a decision to proceed to appropriate treatment.

    ALL of the following

    • The individual has unexplained chronic abdominal pain.
    • The examination is intended to confirm a diagnosis and inform treatment.
    • The sequence and chronology of testing and treatment before capsule endoscopy have been adequately defined to establish clinical utility.

    Ulcerative Colitis

    The purpose of wireless capsule endoscopy for ulcerative colitis would be to inform management decisions based on disease status.

    ALL of the following

    • The individual has ulcerative colitis.
    • The examination is intended to assess disease status and inform management decisions.

    Hereditary Gastrointestinal Polyposis Syndromes

    Wireless capsule endoscopy may be considered medically necessary for small-bowel surveillance in hereditary gastrointestinal polyposis syndromes.

    Applicable syndromes

    • Familial adenomatous polyposis.
    • Peutz-Jeghers syndrome.

    Ulcerative Colitis: Evidence Limitations

    Evidence for wireless capsule endoscopy in ulcerative colitis is limited.

    ALL of the following

    • Diagnostic-accuracy studies have compared capsule endoscopy with colonoscopy for disease activity, but data are limited; two of four studies included fewer than 50 patients.
    • No randomized controlled trials assessing the clinical utility of wireless capsule endoscopy for ulcerative colitis were identified.
    • Additional evidence is needed to determine the impact on net health outcomes.

    Esophageal Disorders

    Other available modalities are superior to wireless capsule endoscopy for monitoring esophageal disorders.

    ALL of the following

    • Wireless capsule endoscopy has generally demonstrated inferior diagnostic characteristics compared with traditional upper endoscopy for esophageal conditions.
    • Wireless capsule endoscopy cannot substitute for traditional endoscopy or triage patients to endoscopy because of inadequate sensitivity and specificity.

    Portal Hypertensive Enteropathy

    Capsule endoscopy has been used to diagnose portal hypertensive enteropathy, but its diagnostic performance and clinical utility are limited.

    ALL of the following

    • Systematic reviews report limited sensitivity and specificity for the relevant findings.
    • Capsule endoscopy should not be used instead of esophagogastroduodenoscopy or to triage patients to esophagogastroduodenoscopy.
    • The available diagnostic characteristics do not demonstrate clinical utility.

    Acute Upper Gastrointestinal Tract Bleeding

    The purpose of wireless capsule endoscopy for acute upper gastrointestinal tract bleeding would be to inform management decisions based on disease status.

    ALL of the following

    • The individual has acute upper gastrointestinal tract bleeding.
    • The examination is intended to inform management decisions based on disease status.
    • Because evidence is insufficient and guidelines do not recommend this use, the examination is investigational.

    Colon Cancer Screening

    The purpose of wireless capsule endoscopy for colon cancer screening would be to confirm a diagnosis and inform a decision to proceed to appropriate treatment.

    ALL of the following

    • The individual is being screened for colon cancer.
    • The examination is intended to confirm a diagnosis and inform treatment.
    • The use is investigational because evidence is insufficient and diagnostic performance is worse than standard colonoscopy.

    Lower Gastrointestinal Tract Bleeding and Major Risks for Colonoscopy or Moderate Sedation

    Wireless capsule endoscopy for lower gastrointestinal bleeding in individuals at major risk for colonoscopy or moderate sedation is investigational.

    ALL of the following

    • There is evidence of gastrointestinal bleeding of lower gastrointestinal origin.
    • The individual has major risks for colonoscopy or moderate sedation.
    • The proposed purpose is to visualize the colon for polyps or another source of bleeding and guide further treatment or testing.

    Suspected Small-Bowel Bleeding: Required Criteria

    Wireless capsule endoscopy may be considered medically necessary for suspected small-bowel bleeding when all of the following are met.

    ALL of the following

    • The individual has recurrent, obscure gastrointestinal bleeding with suspected small-bowel bleeding.
    • Prior upper and lower gastrointestinal endoscopic studies are inconclusive.
    • The examination can locate the source of bleeding and direct treatment to that source.

    Crohn's Disease: Qualifying Scenarios

    Wireless capsule endoscopy may be considered medically necessary for Crohn's disease in either of the following scenarios.

    ONE of the following

    • Initial diagnosis of suspected small-bowel Crohn's disease when clinical signs are present and conventional diagnostic tests do not show the disease.
    • Established Crohn's disease with unexpected changes in disease course or response to treatment.

    Hereditary GI Polyposis Syndromes: Qualifying Criteria

    Wireless capsule endoscopy may be considered medically necessary for small-bowel surveillance in hereditary gastrointestinal polyposis syndromes.

    Qualifying syndromes

    • Familial adenomatous polyposis.
    • Peutz-Jeghers syndrome.

    Suspected Crohn's Disease: Initial Diagnosis

    Initial diagnosis of suspected Crohn's disease requires all of the following.

    ALL of the following

    • Clinical documentation of abdominal pain or diarrhea plus at least one sign of inflammation.
    • The diagnosis has not been confirmed by conventional diagnostic tests, such as small-bowel follow-through, upper and lower endoscopy, MR enterography, or CT enterography.
    • The examination is intended to confirm the diagnosis and inform treatment planning.

    Established Crohn's Disease: Unexpected Change

    In established Crohn's disease, wireless capsule endoscopy may be considered medically necessary when the clinical course or treatment response changes unexpectedly.

    ALL of the following

    • Crohn's disease has been established by prior diagnosis.
    • There is an unexpected change in the course of disease or response to treatment.
    • The examination is needed to reassess disease status and inform management.

    Hereditary GI Polyposis Syndromes: Medical Necessity

    Wireless capsule endoscopy may be considered medically necessary for hereditary gastrointestinal polyposis syndromes when used for small-bowel surveillance.

    ALL of the following

    • The individual has familial adenomatous polyposis, Peutz-Jeghers syndrome, or another qualifying hereditary gastrointestinal polyposis syndrome.
    • The examination is performed for small-bowel surveillance.

    Celiac Disease: Diagnostic or Reassessment Criteria

    Wireless capsule endoscopy may be considered medically necessary for celiac disease in either of the following circumstances.

    ONE of the following

    • Clinical evidence of celiac disease and positive celiac-specific serology in an individual unable to undergo upper endoscopy with biopsy.
    • Re-evaluation of an individual with celiac disease who remains symptomatic despite treatment.

    Gastrointestinal tract obstruction is a contraindication because the capsule may fail to pass and may require surgical removal. Individuals at risk for obstruction require careful specialist evaluation before the procedure.

    Wireless capsule endoscopy cannot replace upper endoscopy or be used to triage patients to upper endoscopy. Other available modalities are superior for esophageal evaluation.

    For portal hypertensive enteropathy or suspected esophageal varices, wireless capsule endoscopy should not be used instead of esophagogastroduodenoscopy or to triage patients to esophagogastroduodenoscopy because diagnostic performance is limited and clinical utility has not been demonstrated.

    Routine small-bowel surveillance with wireless capsule endoscopy is not generally recommended for individuals with Lynch syndrome. Evidence is insufficient to establish that surveillance improves outcomes.

    Wireless capsule endoscopy cannot substitute for esophagogastroduodenoscopy or triage patients to esophagogastroduodenoscopy when evaluating portal hypertension, esophageal varices, or other upper gastrointestinal disorders.

    Wireless capsule endoscopy is contraindicated when small-bowel obstruction or stricture is known or suspected because the capsule may not pass naturally and may require surgical removal.

    Routine wireless capsule endoscopy is not indicated for surveillance.

    Wireless capsule endoscopy is not the preferred initial workup for suspected small-bowel adenocarcinoma because it cannot obtain tissue for diagnosis. It may be considered only after radiographic imaging and other forms of endoscopy fail to reveal a suspected primary lesion.

    Evaluation of the esophagus with wireless capsule endoscopy, including for gastroesophageal reflux or other esophageal pathologies, is investigational.

    Wireless capsule endoscopy is investigational for nonqualifying gastrointestinal conditions, including irritable bowel syndrome, hereditary nonpolyposis syndromes such as Lynch syndrome, small-bowel neoplasm, portal hypertensive enteropathy, lower gastrointestinal bleeding, incomplete colonoscopy, and unexplained chronic abdominal pain.

    Wireless capsule endoscopy is investigational for colon cancer screening because evidence is insufficient to show improved health outcomes and diagnostic performance is worse than standard colonoscopy.

    Wireless capsule endoscopy is investigational for acute upper gastrointestinal tract bleeding because evidence is insufficient to show improved health outcomes and clinical guidelines do not recommend this use.

    Patency capsules are investigational for all indications, including evaluation of gastrointestinal tract patency before wireless capsule endoscopy. Evidence does not establish improved net health outcomes compared with other strategies, and adverse events may include small-bowel obstruction and perforation.

    Magnetic capsule endoscopy is investigational for all indications because research has not shown improved health outcomes and no evidence-based clinical guidelines recommend it.

    An upper gastrointestinal optical sensor capsule, including the PillSense System, is investigational for all indications because research has not shown improved health outcomes and evidence-based clinical guidelines do not recommend it.

    Wireless capsule endoscopy for small-bowel evaluation is investigational when the medically necessary criteria are not met.

    Wireless capsule endoscopy is investigational for nonqualifying esophageal evaluation, colon evaluation or screening, acute upper gastrointestinal bleeding, lower gastrointestinal bleeding, and evaluation following incomplete colonoscopy.

    Portal hypertensive enteropathy lacks demonstrated clinical utility because diagnostic sensitivity and specificity are limited. Wireless capsule endoscopy should not replace or triage to esophagogastroduodenoscopy.

    Routine small-bowel surveillance is not generally recommended for Lynch syndrome because available evidence is insufficient regarding lesion prevalence, natural history, and improved patient outcomes.

    The American Gastroenterological Association recommends against using capsule endoscopy to diagnose Crohn's disease when chronic abdominal pain or diarrhea are the only symptoms and there is no evidence of biomarkers.

    The American Gastroenterological Association recommends against using capsule endoscopy for diagnosing celiac disease.

    The American Gastroenterological Association recommends against routine substitution of capsule endoscopy for colonoscopy and against using capsule endoscopy as a substitute for colonoscopy to assess the extent or severity of inflammatory bowel disease.

    Coding Information

    CPTCPT
    0651TMagnetically controlled capsule endoscopy, esophagus through stomach, including intraprocedural positioning of capsule, with interpretation and report
    Upper gastrointestinal blood detection, sensor capsule, with interpretation and report
    91111Gastrointestinal tract imaging, intraluminal (eg, capsule endoscopy), esophagus through ileum, with interpretation and report
    91113Gastrointestinal tract imaging, intraluminal (eg, capsule endoscopy), colon, with interpretation and report
    91299Unlisted diagnostic gastroenterology procedure
    Significant polyps
    ThresholdPolyps >6 mm or ≥3 polyps
    Significant polyps
    ThresholdPolyps ≥6 mm or ≥3 polyps
    Significant polyps
    ThresholdPolyps >5 mm or ≥3 polyps

    Provider Actions and Review Requirements

    Documentation Required

    Submit Records for Medical-Necessity Review

    Submit clinical documentation supporting the requested wireless capsule endoscopy so the medical-necessity criteria can be evaluated. Missing information may affect the review and decision outcome.

    • Medical records related to Criterion I
    • History and physical or chart notes
    • Description of the suspected disorder
    Documentation Required

    Prior Endoscopic Evaluation Required

    For suspected small-bowel bleeding, document that prior upper and lower GI endoscopic studies performed during the current episode of illness were inconclusive.

    • Include records of both prior upper and lower GI endoscopic studies
    • Studies must have been performed during the current episode of illness
    • The studies must be inconclusive

    Background

    Wireless capsule endoscopy uses an ingested disposable capsule containing video imaging, illumination, image transmission, and battery components. As the capsule passes through the gastrointestinal tract, it captures and wirelessly transmits images to a recorder worn around the waist; the images are later downloaded for interpretation. Battery life is up to 8 hours, and average transit from ingestion to evacuation is approximately 24 hours.

    Definitions and Abbreviations

    Definitions
    DefinitionA noninvasive procedure in which an individual swallows a capsule containing imaging or light-absorption sensors; the capsule transmits images as it travels through the gastrointestinal tract, is excreted, and the recorded images are interpreted.
    Definitions
    DefinitionThe portion of the gastrointestinal tract primarily evaluated under the medically necessary criteria in this policy.
    Definitions
    DefinitionA capsule used to verify GI tract patency before wireless capsule endoscopy; patency capsules are investigational for all indications under this policy.

    Covered Indications

    Evaluation of Suspected Small-Bowel Bleeding

    Covered evaluation requires recurrent obscure bleeding and inconclusive prior endoscopic studies.

    The individual has recurrent, obscure GI bleeding with suspected small-bowel bleeding, and prior upper and lower GI endoscopic studies are inconclusive.

    Evaluation of Crohn's Disease

    Covered Crohn's disease evaluation follows one of two qualifying pathways.

    ONE pathway

    • Initial suspected Crohn's disease: abdominal pain or diarrhea plus at least one sign of inflammation, with no prior confirmation by conventional diagnostic testing.
    • Established Crohn's disease: unexpected change in disease course or response to treatment suggesting re-examination may be indicated.

    Frequency Limits

    Frequency limits
    IntervalEvery 5 years.
    Frequency limits
    IntervalEvery 2-3 years; shorter intervals may be indicated based on polyp size, number, and pathology.

    Prior Authorization

    Prior Authorization

    Submit clinical documentation with the request

    Clinical documentation must be submitted for review to determine whether policy criteria are met. Include records supporting the applicable indication and required clinical findings.

    Not Covered

    The following uses and technologies are not covered because they are considered investigational: wireless capsule endoscopy for small-bowel evaluation outside the specified medically necessary criteria; esophageal disorders; nonqualifying gastrointestinal conditions; colon cancer screening; acute upper gastrointestinal bleeding; lower gastrointestinal bleeding; incomplete-colonoscopy evaluation; and routine surveillance. Patency capsules, magnetic capsule endoscopy, and upper gastrointestinal optical sensor capsules are investigational for all indications.

    Policy Summary
    PayerRegence BlueCross BlueShield
    PolicyWireless Capsule Endoscopy for Gastrointestinal (GI) Disorders
    Policy CodePolicy N/A
    Change TypeNo material change
    Effective DateAugust 1, 2026
    Last ReviewMar 1, 2026
    Next Review DateJanuary 1, 2027
    Key ActionSubmit clinical documentation supporting the medical-policy criteria for review.
    SourceLink
    On This Page
    Coverage CriteriaCoding InformationProvider Actions and Review RequirementsBackgroundDefinitions and AbbreviationsCovered IndicationsFrequency LimitsPrior AuthorizationNot Covered
  1. Initial evaluation of acute upper gastrointestinal bleeding.
  2. Evaluation of lower gastrointestinal bleeding, including when there are major risks for colonoscopy or moderate sedation.
  3. Evaluation following incomplete colonoscopy.
  4. Patency capsule for any indication, including evaluation of gastrointestinal tract patency before wireless capsule endoscopy.
  5. Magnetic capsule endoscopy for any indication, including unexplained upper abdominal complaints.
  6. Upper gastrointestinal optical sensor capsule, including for suspected upper gastrointestinal bleeding.
  7. Denial Risk

    Exclude Obstruction or Stricture

    Confirm that gastrointestinal obstruction or stricture has been excluded before capsule endoscopy. Retention may occur if an obstruction or stricture prevents the capsule from passing naturally.

    • Known or suspected small-bowel obstruction or stricture is a contraindication
    • Evaluate other potential obstacles, including relevant fistulae or motility disorders, as clinically appropriate
    Documentation Required

    Document Clinical History and Suspected Disorder

    Provide the clinical history and suspected disorder supporting the request, including documentation showing how the requested study relates to Criterion I.

    • History and physical or chart notes
    • Description of the suspected disorder
    • Relevant clinical signs, symptoms, and treatment response
    Documentation Required

    Supporting Diagnostic Records

    Submit supporting diagnostic records relevant to the medical-necessity review.

    • Previous imaging or diagnostic testing results, if any
    • Documentation of signs of inflammation that are nondiagnostic on conventional tests, when relevant
    • Conservative treatment provided, if any
    • Genetic syndrome testing, when relevant
    Documentation Required

    Document the Bleeding Evaluation

    For suspected small-bowel bleeding, document the current episode and the clinical evidence of gastrointestinal bleeding.

    • Anemia, such as iron-deficiency anemia
    • Positive fecal occult blood test
    • Visible bleeding
    • Recurrent or obscure bleeding, when applicable
    Documentation Required

    Document Crohn’s Disease Criteria

    For Crohn’s disease requests, document the symptoms, evidence of inflammation, disease status, and prior diagnostic testing supporting the indication.

    • Suspected disease: abdominal pain or diarrhea plus at least one sign of inflammation
    • Examples include fever, elevated white blood cell count, elevated ESR or CRP, bleeding, or terminal ileitis
    • Established disease: unexpected changes in disease course or response to treatment
    • For initial diagnosis, document that conventional diagnostic tests have not confirmed the diagnosis
    • Conventional testing may include small-bowel follow-through, upper and lower endoscopy, MR enterography, or CT enterography
    Documentation Required

    Suspected Small-Bowel Bleeding Documentation

    For suspected small-bowel bleeding, submit a complete documentation checklist showing that the policy criteria are met.

    • Current-episode upper and lower GI endoscopy reports showing inconclusive findings
    • Clinical documentation of suspected GI bleeding
    • Anemia, positive fecal occult blood test, or visible bleeding
    • Relevant history and physical or chart notes
    Documentation Required

    Crohn’s Disease Indication Documentation

    For Crohn’s disease, document whether the request is for initial diagnosis of suspected disease or re-evaluation of established disease and provide the corresponding clinical evidence.

    • Initial diagnosis: abdominal pain or diarrhea plus one or more signs of inflammation
    • Initial diagnosis: no prior confirmation by conventional diagnostic tests
    • Established disease: unexpected change in disease course or response to treatment
    Documentation Required

    Hereditary Polyposis Syndrome Documentation

    For hereditary gastrointestinal polyposis syndromes, document the qualifying syndrome and the need for small-bowel surveillance.

    • Familial adenomatous polyposis
    • Peutz-Jeghers syndrome
    • Relevant genetic or syndrome testing, when available
    Denial Risk

    Investigational Indication or Technology

    Wireless capsule endoscopy is investigational for evaluation of the small bowel when Criterion I is not met and for all other indications listed in the policy. Requests that do not meet the medical-necessity criteria are subject to denial as investigational.

    • Document the specific medically necessary indication
    • Do not assume capsule endoscopy is covered for an indication outside Criterion I
    • Patency, magnetic, and optical sensor capsule technologies are investigational for all indications
    Denial Risk

    Failure to Meet Medical-Necessity Criteria

    If the applicable medical-necessity criteria are not met, wireless capsule endoscopy is considered investigational and may be denied.

    • Suspected small-bowel bleeding when prior upper and lower endoscopies are not inconclusive
    • Crohn’s disease when the required symptoms, inflammation, disease status, or prior testing criteria are not documented
    • Celiac disease when applicable policy criteria are not met
    • Other indications outside Criterion I
    Denial Risk

    Obstruction or Contraindication Risk

    Complete a safety review before capsule endoscopy. Obstruction, stenosis, or other contraindications can result in capsule retention or other complications.

    • Evaluate for known or suspected GI obstruction or small-bowel stricture
    • Assess patients at risk for obstruction, swallowing disorders, fistulae, relevant diverticulosis, or motility disorders
    • Specialist evaluation may be needed for patients with pacemakers or other implanted cardiac devices, or who are pregnant
    • Magnetic capsule endoscopy is contraindicated with obstruction, stenosis, fistula, dysphagia, or certain implanted electronic devices
    Denial Risk

    Do Not Substitute for or Triage to EGD

    Do not use wireless capsule endoscopy as a substitute for upper endoscopy or to triage patients to upper endoscopy for esophageal varices. Its lower sensitivity and specificity do not support replacing traditional endoscopy.

    • Traditional esophagogastroduodenoscopy remains the appropriate reference examination
    • Capsule findings should not delay or determine referral for upper endoscopy
    Denial Risk

    Limited Utility in Portal Hypertensive Enteropathy

    Capsule endoscopy has limited sensitivity and specificity for portal hypertensive enteropathy and esophageal varices and does not appear to have clinical utility for this use.

    • Do not use capsule endoscopy instead of esophagogastroduodenoscopy
    • Do not use capsule endoscopy to triage patients to esophagogastroduodenoscopy
    Denial Risk

    Lynch Syndrome Surveillance Is Not Routine

    Routine small-bowel surveillance with capsule endoscopy is not generally recommended for patients with Lynch syndrome. Evidence is sufficient for selected hereditary polyposis syndromes such as familial adenomatous polyposis and Peutz-Jeghers syndrome, but not for routine Lynch syndrome surveillance.

    • Lynch syndrome is a hereditary nonpolyposis syndrome
    • Additional data are needed to establish benefit and improve outcomes
    Denial Risk

    Do Not Substitute for or Triage to EGD for Esophageal Varices

    Do not use capsule endoscopy instead of or as a triage test for EGD when evaluating esophageal varices. The technology does not have adequate diagnostic characteristics to replace traditional endoscopy.

    • Use esophagogastroduodenoscopy for appropriate evaluation and management
    • Capsule endoscopy should not delay referral for EGD
    Denial Risk

    Insufficient Evidence for Colon Cancer Screening Efficacy

    Diagnostic-characteristic studies alone do not establish the efficacy of capsule endoscopy for colon cancer screening. Its performance is worse than standard colonoscopy, and direct clinical-trial evidence of screening efficacy is lacking.

    • Do not use capsule endoscopy as a routine substitute for colonoscopy
    • Modeling or diagnostic-performance data do not establish prevention of colon cancer mortality
    • Evidence is insufficient to demonstrate colon cancer screening efficacy
    Denial Risk

    Obstruction or Stricture Is a Contraindication

    Capsule endoscopy is contraindicated when small-bowel obstruction or stricture exists because the capsule may be retained and require surgical removal.

    • Exclude obstruction before the procedure
    • Exclude strictures and other conditions that may prevent natural capsule passage
    Denial Risk

    Routine Surveillance Is Not Indicated

    Routine capsule endoscopy is not indicated for surveillance unless the patient has a covered indication, such as surveillance of the small bowel for a qualifying hereditary GI polyposis syndrome.

    • Routine surveillance is not supported for nonspecific or unsupported indications
    • Lynch syndrome surveillance is not generally recommended
    Denial Risk

    Unsupported or Substitute Use

    Follow AGA recommendations and do not use capsule endoscopy for unsupported substitute uses. In particular, capsule endoscopy should not routinely replace colonoscopy or substitute for colonoscopy to assess the extent or severity of inflammatory bowel disease.

    • Do not substitute capsule endoscopy for colonoscopy
    • Do not use capsule endoscopy as a substitute for colonoscopy in IBD assessment
    • Do not diagnose Crohn’s disease when chronic abdominal pain or diarrhea are the only symptoms and biomarkers are absent
    • Do not use capsule endoscopy for celiac disease when the recommendation is against its use
    Denial Risk

    Criteria Not Met: Investigational Status

    When the applicable medical-necessity criteria are not met, capsule endoscopy for suspected small-bowel bleeding, Crohn’s disease, or celiac disease is considered investigational.

    • Suspected small-bowel bleeding: criteria must include inconclusive prior upper and lower endoscopy and documented suspected bleeding
    • Crohn’s disease: required clinical findings and prior-testing criteria must be documented
    • Celiac disease: applicable policy criteria must be met
    Denial Risk

    Investigational Gastrointestinal Indications

    The following gastrointestinal indications are investigational because evidence is insufficient to show improved health outcomes or guidelines do not recommend capsule endoscopy for these uses.

    • Esophageal disorders, including gastroesophageal reflux and other esophageal pathologies
    • Irritable bowel syndrome
    • Hereditary nonpolyposis syndromes, including Lynch syndrome
    • Small-bowel neoplasm
    • Portal hypertensive enteropathy
    • Lower GI tract bleeding
    • Incomplete colonoscopy
    • Unexplained chronic abdominal pain
    • Evaluation of the extent of known Crohn’s disease or ulcerative colitis
    • Initial evaluation of acute upper GI bleeding
    Denial Risk

    Investigational Capsule Technologies

    Patency capsules, magnetic capsule endoscopy, and upper GI optical sensor capsules are investigational for all indications.

    • Patency capsule: investigational, including use to evaluate GI tract patency before wireless capsule endoscopy
    • Magnetic capsule endoscopy: investigational for all indications
    • Upper GI optical sensor capsule, such as PillSense System™: investigational for all indications, including suspected upper GI bleeding
    Definitions
    DefinitionA test that detects the presence or absence of a condition, future risk, or treatment response and is supported by appropriate population selection, a credible reference standard, and diagnostic performance measures.
    Definitions
    DefinitionA test whose results inform management decisions that improve net health outcomes, such as providing correct or more effective therapy or avoiding unnecessary therapy or testing.
    Definitions
    DefinitionEvidence comparing health outcomes for individuals managed with and without the test; randomized controlled trials are preferred.
    Definitions
    CECapsule endoscopy.
    CCEColon capsule endoscopy.
    Definitions
    CDCrohn's disease.
    Definitions
    MREMagnetic resonance enterography.
    Definitions
    MRECMagnetic resonance enterocolonography.
    Definitions
    CE-1First-generation capsule endoscopy.
    Definitions
    CE-2Second-generation capsule endoscopy.
    Definitions
    MESMayo Endoscopic Subscore, an endoscopic measure used to characterize ulcerative colitis activity.
    Definitions
    PPVPositive predictive value.
    Definitions
    NPVNegative predictive value.
    Definitions
    ICCIntraclass correlation coefficient.
    Definitions
    CECapsule endoscopy.
    Definitions
    EGDEsophagogastroduodenoscopy.
    Definitions
    GBSGlasgow Blatchford score.
    Definitions
    VCEVideo capsule endoscopy.
    Definitions
    CCEColon capsule endoscopy.
    Definitions
    CECapsule endoscopy.
    Definitions
    CRCColorectal cancer.
    Definitions
    CTCComputed tomography colonography.
    Definitions
    FOBTFecal occult blood test.
    Definitions
    OCOptical colonoscopy.
    Definitions
    CCEColon capsule endoscopy.
    Definitions
    CCECapsule colonoscopy or colon capsule endoscopy.
    Definitions
    CECapsule endoscopy.
    Definitions
    CIConfidence interval.
    Definitions
    CRCColorectal cancer.
    Definitions
    ICIncomplete colonoscopy.
    Definitions
    OCOptical colonoscopy.
    Definitions
    SBCESmall-bowel capsule endoscopy.
    Definitions
    DefinitionA capsule used to assess gastrointestinal tract patency before video capsule endoscopy.
    Definitions
    DefinitionA single-use digestible capsule that wirelessly transmits light-absorption data and provides a yes/no blood-detection readout for suspected upper gastrointestinal bleeding.
    Definitions
    DefinitionBleeding after upper and lower gastrointestinal sources have been excluded; the term replaces 'obscure gastrointestinal bleeding' when a source cannot be identified anywhere in the gastrointestinal tract.

    Small-Bowel Surveillance in Hereditary GI Polyposis Syndromes

    Small-bowel surveillance may be considered for specified hereditary GI polyposis syndromes.

    The individual has a hereditary GI polyposis syndrome, including familial adenomatous polyposis or Peutz-Jeghers syndrome.

    Evaluation or Re-Evaluation of Celiac Disease

    Evaluation or re-evaluation of celiac disease may be considered in either of the following circumstances.

    ONE circumstance

    • Clinical evidence of celiac disease and positive celiac-specific serology are present, and upper endoscopy with biopsy is not indicated or cannot be performed.
    • Known celiac disease remains symptomatic despite treatment and requires re-evaluation.

    Suspected Small-Bowel Bleeding

    Covered evaluation is intended to confirm the bleeding source and direct treatment after inconclusive endoscopy.

    The individual has recurrent, obscure GI bleeding with suspected small-bowel bleeding, and prior upper and lower GI endoscopic studies are inconclusive.

    Established Crohn's Disease

    In established Crohn's disease, the examination is intended to inform management based on disease status.

    The individual has established Crohn's disease with an unexpected change in disease course or response to treatment.

    Suspected Crohn's Disease

    In suspected Crohn's disease, the examination is intended to confirm diagnosis and inform treatment planning.

    The individual has clinical signs of suspected Crohn's disease and conventional diagnostic tests do not show evidence of disease.

    Suspected Crohn's Disease When Other Modalities Are Nondiagnostic

    Capsule endoscopy may be considered when other diagnostic modalities cannot establish suspected Crohn's disease.

    The individual has suspected Crohn's disease that remains undiagnosed by other modalities, and capsule endoscopy is used for diagnostic confirmation and treatment planning.

    Equivocal, Difficult-to-Confirm, or Unresponsive Celiac Disease

    Capsule endoscopy may be considered in selected equivocal, difficult-to-confirm, or unresponsive cases.

    ONE circumstance

    • Celiac disease is equivocal or upper endoscopy with biopsy is not possible, and capsule endoscopy is used to identify compatible small-bowel morphologic changes.
    • Known celiac disease is unresponsive to treatment, and capsule endoscopy is used to evaluate for potentially actionable diagnoses.

    Unexplained Chronic Abdominal Pain

    The stated purpose is diagnostic confirmation and treatment planning, but the required preceding workup is not defined.

    The individual has unexplained chronic abdominal pain, and capsule endoscopy is being used to confirm a diagnosis and inform treatment decisions.

    The evidence is primarily retrospective, and the sequence of testing and treatment before capsule endoscopy remains undefined.

    Ulcerative Colitis Disease-Status Assessment

    The stated purpose is to inform management decisions based on ulcerative-colitis disease status.

    The individual has ulcerative colitis, and capsule endoscopy is being used for disease-status assessment.

    No peer-reviewed systematic reviews or randomized controlled trials were identified.

    Small-Bowel Lesion Evaluation in Hereditary GI Polyposis Syndromes

    Capsule endoscopy may identify additional small-bowel lesions in selected hereditary polyposis syndromes.

    Qualifying syndrome

    • Familial adenomatous polyposis is present.
    • Peutz-Jeghers syndrome is present.

    Assessment of Ulcerative Colitis Activity or Extent

    Capsule endoscopy has been studied for ulcerative-colitis activity and extent, but evidence and clinical utility remain uncertain.

    The individual has ulcerative colitis and capsule endoscopy is being considered to assess disease activity or extent.

    Available studies are limited and no randomized controlled trials assessing clinical utility were identified.

    Acute Upper Gastrointestinal Tract Bleeding

    The evidence section describes capsule endoscopy for management or triage decisions in acute upper GI bleeding, but does not establish coverage.

    The individual has suspected acute upper GI bleeding and capsule endoscopy is being considered to inform management, triage, or hospitalization decisions.

    Controlled studies are needed to establish effects compared with standard management.

    Colon Cancer Screening

    The evidence section describes diagnostic confirmation and treatment planning in colon cancer screening, but screening efficacy is unestablished.

    The individual is undergoing colon cancer screening and capsule endoscopy is being considered to detect colorectal polyps or cancer and guide subsequent treatment or testing.

    Diagnostic characteristics alone do not establish screening efficacy or mortality benefit.

    Lower GI Bleeding With Major Colonoscopy or Sedation Risks

    The evidence section describes colonic visualization for lower GI bleeding when colonoscopy or moderate sedation presents major risks.

    The individual has evidence of lower GI bleeding of lower GI origin and major risks for colonoscopy or moderate sedation; capsule endoscopy is being used to visualize the colon and inform further treatment or testing.

    Lower GI Bleeding With Major Colonoscopy or Sedation Risks

    The evidence section describes the same lower-GI bleeding scenario and intended use.

    Evidence of lower GI bleeding and major risks for colonoscopy or moderate sedation are present, and capsule endoscopy is intended to visualize the colon for polyps or other bleeding sources and inform further treatment or testing.

    Incomplete Colonoscopy After Adequate Bowel Preparation

    The evidence population is individuals with incomplete colonoscopy after adequate bowel preparation.

    Colonoscopy was incomplete after adequate bowel preparation and complete evaluation of the colon was not technically possible.

    This is an evidence population, not an established coverage criterion; repeat optical colonoscopy is the comparator of interest.

    Colon Cancer Screening

    Diagnostic performance alone is insufficient to establish capsule endoscopy as an effective colon cancer screening strategy.

    Use for colon cancer screening would require evidence of screening efficacy and impact on colorectal cancer mortality beyond diagnostic characteristics.

    Evaluation of the Colon After Incomplete Colonoscopy

    The evidence population consists of patients with incomplete colonoscopy after adequate bowel preparation.

    The individual has an incomplete colonoscopy following adequate bowel preparation.

    This is an evidence population; no explicit coverage criterion is established.

    Assessment of GI Tract Patency Before Capsule Endoscopy

    A patency assessment is intended to determine whether the GI tract is sufficiently patent before capsule endoscopy.

    The individual has known or suspected GI or small-bowel strictures and is being evaluated for GI tract patency before capsule endoscopy.

    Patency capsule use is investigational under this policy.

    Magnetic Capsule Endoscopy for Unexplained Upper Abdominal Complaints

    Magnetic capsule endoscopy has been studied for unexplained upper abdominal complaints, but clinical utility is not established.

    The individual has unexplained upper abdominal complaints and magnetic capsule endoscopy is being considered for diagnosis and treatment planning.

    No randomized controlled trials assessing clinical utility were identified.

    Evaluation of Suspected Small-Bowel Bleeding

    Covered evaluation requires recurrent obscure bleeding and inconclusive prior upper and lower endoscopy.

    The individual has recurrent, obscure GI bleeding with suspected small-bowel bleeding, and prior upper and lower GI endoscopic studies are inconclusive.

    Suspected or Established Crohn's Disease

    Evaluation may be considered for suspected or established Crohn's disease in either qualifying scenario.

    ANY of the following

    • Initial suspected Crohn's disease has clinical signs with no evidence on conventional diagnostic testing.
    • Established Crohn's disease has an unexpected change in disease course or response to treatment.

    Hereditary Gastrointestinal Polyposis Syndromes

    Evaluation may be considered for specified hereditary GI polyposis syndromes.

    ANY of the following

    • Familial adenomatous polyposis is present.
    • Peutz-Jeghers syndrome is present.

    Suspected Small-Bowel Crohn's Disease

    Initial evaluation of suspected small-bowel Crohn's disease requires clinical signs and nondiagnostic conventional testing.

    Clinical signs of suspected small-bowel Crohn's disease are present, and conventional diagnostic tests do not show evidence of disease.

    Established Crohn's Disease

    Re-evaluation may be considered when established Crohn's disease changes unexpectedly.

    The individual has established Crohn's disease with an unexpected change in the course of disease or response to treatment.

    Hereditary Gastrointestinal Polyposis Syndromes

    Evaluation may be considered for a hereditary gastrointestinal polyposis syndrome.

    The individual has familial adenomatous polyposis, Peutz-Jeghers syndrome, or another hereditary gastrointestinal polyposis syndrome.

    Celiac Disease When Upper Endoscopy With Biopsy Cannot Be Performed

    Capsule endoscopy may be considered when celiac disease is clinically suspected and upper endoscopy with biopsy cannot be performed.

    There is clinical evidence of celiac disease and positive celiac-specific serology, and the individual is unable to undergo upper endoscopy with biopsy.

    Re-Evaluation of Symptomatic Celiac Disease

    Re-evaluation may be considered for symptomatic celiac disease despite treatment.

    The individual has known celiac disease with persistent symptoms despite treatment and requires re-evaluation.